What are the causes of retroplacental (behind the placenta) hematoma?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Causes of Retroplacental Hematoma

The primary causes of retroplacental hematoma include placental abruption, hypertensive disorders of pregnancy (pre-eclampsia/HELLP syndrome), uterine trauma, and coagulation disorders. 1, 2

Definition and Pathophysiology

Retroplacental hematoma (RPH) refers to bleeding that occurs between the placenta and the uterine wall, often as a manifestation of placental abruption. It involves an acute intradecidual vascular accident with rupture of uteroplacental arterioles 3.

Major Causes

1. Hypertensive Disorders

  • Pre-eclampsia
  • HELLP syndrome (Hemolysis, Elevated Liver enzymes, Low Platelets)
  • Chronic hypertension

2. Decidual Defects

  • Basal plate myometrial fibers (BPMF) - areas where decidua is deficient, allowing direct contact between trophoblast and myometrium 1
  • Prior uterine surgery or trauma creating decidual defects

3. Trauma-Related Factors

  • Uterine trauma
  • External abdominal trauma
  • Uterine rupture

4. Coagulation Disorders

  • Inherited coagulopathies
  • Acquired coagulopathies (e.g., related to amniotic fluid embolism)

5. Obstetric Risk Factors

  • Multiple parity (paradoxically appears protective in some studies) 4
  • Inadequate prenatal care (fewer than 4 antenatal visits) 4
  • Advanced maternal age
  • Smoking
  • Polyhydramnios

Clinical Presentation and Diagnosis

Retroplacental hematoma may present with:

  • Complete clinical syndrome: shock, uterine contracture, absence of fetal heart sounds
  • Incomplete syndrome (42.8% of cases): back pain and vaginal bleeding without shock or contracture, with fetal heart sounds still present 5

Diagnostic imaging findings include:

  • Ultrasound: linear or biconcave, well-marginated mixed echogenic or anechoic region posterior to the placenta 6
  • Secondary signs: intraplacental anechoic regions, intra-amniotic hemorrhage, bulging of the chorionic plate 6
  • CT: may show hematoma within the uterine cavity 1

Associated Complications

Retroplacental hematoma is associated with:

  • Fetal mortality in utero (13.2 times higher risk) 4
  • Low birth weight (<2500g) 4
  • Need for blood transfusion 4
  • Maternal hemorrhage and potential shock
  • Coagulopathy (consumption coagulopathy)

Prevention and Risk Reduction

  • Regular, high-quality prenatal care is essential for prevention 4
  • Early identification of high-risk patients (those with hypertensive disorders, prior uterine surgery)
  • Management of underlying conditions (hypertension, coagulopathies)

Clinical Significance

The frequency of retroplacental hematoma is estimated at 0.13-1.38% of pregnancies 3, with a recent study reporting 5.20% 4. It represents a serious obstetric emergency that can lead to significant maternal and fetal morbidity and mortality if not promptly diagnosed and managed.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Postpartum Hemorrhage Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Placental abruption: etiopathogenic aspects, diagnostic and therapeutic implications.

Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie, 2018

Research

[Retroplacental hematoma with incomplete symptoms].

Revue francaise de gynecologie et d'obstetrique, 1984

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.